Imperial College London
Portrait Picture

Professor Thanos Athanasiou MD PhD MBA FECTS FRCS

Faculty of Medicine, Department of Surgery & Cancer

Professor of Cardiovascular Sciences
 
 
 
//

Contact

 

t.athanasiou

 
 
//

Location

 

1022Queen Elizabeth the Queen Mother Wing (QEQM)St Mary's Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Aziz:2005,
author = {Aziz, O and Athanasiou, T and Darzi, A},
journal = {Surg Technol Int},
pages = {35--40},
title = {Haemostasis using a ready-to-use collagen sponge coated with activated thrombin and fibrinogen.},
url = {https://www.ncbi.nlm.nih.gov/pubmed/16525952},
volume = {14},
year = {2005}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Adequate haemostasis is an important part of any surgical procedure, but particularly so in the case of visceral organ surgery where apparently insignificant ooze can ultimately result in significant haemorrhage and coagulopathy. To achieve haemorrhage control, the surgeon may use conventional techniques (eg, suture ligation, diathermy, and swab compression), but failing this has the option of using physical coagulation tools (eg, the argon beam coagulator) and haemostasis adjuncts (eg, fibrin glues and collagen sheets). Advances in manufacturing have led to development of several other haemostatic products including absorbable gelatin sponges, cyanoacrylates, and polymer-based adhesives. One such product consists of a fixed, ready-to-use equine collagen sponge coated with human thrombin and fibrinogen. It may be applied directly to the bleeding surface, without the need for preparation or reconstitution. This chapter reviews the published evidence and compares its use to other classes of haemostasis adjuncts across a range of surgical specialties, namely hepatic, splenic, thoracic, vascular, and minimally invasive surgery. It also aims to highlight the apparent advantages and limitations of the fibrinogen and thrombin-coated collagen sponge compared to other commercially available haemostasis adjuncts, and identify potential applications for the product.
AU  - Aziz,O
AU  - Athanasiou,T
AU  - Darzi,A
EP  - 40
PY  - 2005///
SN  - 1090-3941
SP  - 35
TI  - Haemostasis using a ready-to-use collagen sponge coated with activated thrombin and fibrinogen.
T2  - Surg Technol Int
UR  - https://www.ncbi.nlm.nih.gov/pubmed/16525952
VL  - 14
ER  -
Download